Three independent biological replicates on separate days. Within each, 4 technical replicate wells per condition (control vehicle, 10 µM Y-27632) in a standardized scratch assay. Imaging spans 18 h with frames every 10 min at 37 C / 5% CO2 in an environmental stage chamber. Wound width is standardized using a culture-insert (500 µm gap) rather than a manual scratch to reduce edge-roughness variability. Two non-overlapping positions per well are imaged via a motorized stage. Wells are randomized across the plate to distribute positional/edge effects.
BSL-2 for MDCK culture; work in a biosafety cabinet. Mitomycin C is a potent mutagen/carcinogen — handle in a fume hood with double nitrile gloves and dedicated chemical waste; weigh and dissolve with minimal aerosolization. Y-27632 is a research chemical; avoid skin contact. HEPES-buffered medium reduces CO2 dependence but should still be handled sterilely. Phase-contrast LED illumination poses minimal hazard. Biological waste autoclaved or 10% bleach treated; mitomycin waste segregated per institutional hazardous-waste policy. Wear gloves, lab coat, eye protection.
Vehicle control: matched volume of water/DMSO in which Y-27632 is dissolved. Proliferation control: paired wells with and without mitomycin C to confirm that closure reflects migration, not division. Positive migration control: untreated confluent monolayer with a known closure rate (~25-35 µm/h for MDCK). Negative/no-gap control: an uninjured confluent region imaged in parallel to confirm baseline stability and absence of drift artifacts. A cell-free medium-only position controls for autofocus and illumination drift.
Control monolayers should close the 500 µm gap in roughly 14-18 h at ~25-35 µm/h with a smooth, coherent leading edge (order parameter ~0.6-0.8). Y-27632-treated wells should show faster closure (~35-45 µm/h) but a rougher, less coordinated front (order parameter ~0.3-0.5). PIV velocity fields should reveal organized front-directed flow in controls and more disordered, swirling flow under ROCK inhibition. Good data have stable focus throughout, <5% evaporation-driven medium-osmolarity change, and reproducible closure curves across technical replicates.
To quantify collective cell migration dynamics during scratch-wound closure in a confluent MDCK monolayer using long-duration live-cell phase-contrast imaging. The assay yields both a population-level wound-closure rate (µm/h) and a spatially resolved velocity field via PIV, enabling assessment of how the ROCK inhibitor Y-27632 alters migration speed and front coordination.
Independent variable: ROCK inhibition (10 µM Y-27632 vs vehicle). Dependent variables: wound-closure rate (µm/h), percent wound area closed over time, mean migration speed from PIV (µm/h), and the velocity order parameter (directional coherence, 0-1). Controlled variables: initial gap width (500 µm insert), monolayer confluency at scratch, imaging medium and HEPES buffering, temperature/CO2/humidity, frame interval, objective and illumination, and proliferation state (mitomycin C).
We hypothesize that ROCK inhibition with 10 µM Y-27632 increases the wound-closure rate by reducing rear-edge retraction tension while decreasing the directional coherence (order parameter) of the leading front, consistent with a more fluid but less coordinated migration mode compared to vehicle-treated monolayers.
Wound area per frame is segmented in Fiji using the MRI Wound Healing Tool or a variance-filter mask; closure rate is the slope of the linear closure phase. Velocity fields are computed with PIVlab (MATLAB) or the Fiji PIV plugin on consecutive frame pairs (interrogation window 64 -> 32 px, 50% overlap). Mean speed and the velocity order parameter (mean normalized velocity vector magnitude) are extracted per frame. Drift is corrected via the StackReg/rigid-body registration before PIV. All segmentation thresholds and PIV parameters are fixed across conditions and reported.
Per-well closure rates and mean order parameters (n = 4 technical replicates nested within 3 biological replicates) are compared with a linear mixed-effects model or, if simplified, an unpaired two-tailed t-test on biological-replicate means (n = 3) at alpha = 0.05. Closure curves are compared by fitting and comparing slopes (ANCOVA). With 3 biological replicates and an expected ~30% rate difference (effect size d ~2), power exceeds 0.85. Technical replicates are averaged before the biological-level test to avoid pseudoreplication.